Advent Bioservices vs Thermo Fisher Scientific: CDMO Comparison

Side-by-side comparison of Advent Bioservices and Thermo Fisher Scientific on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

London, UK
Signal Score
78/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
Modalities
AAV, Lentiviral, Adenoviral
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score
83/100
Quality (FDA + GMP)
98/100
FDA inspections
5
— NAI / VAI / OAI
2 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
1
MHRA GMP certificates (compliant)
9
Clinical programs (matched)
2
Capacity
Available
Modalities
AAV, Lentiviral, Plasmid DNA, Adenoviral

Key differences

  • Thermo Fisher Scientific has more FDA inspections on record (5 vs 0) — a deeper regulatory paper trail.
  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Thermo Fisher Scientific holds 1 active EMA GMP certificates; Advent Bioservices does not appear in EudraGMDP.
  • Thermo Fisher Scientific has stronger MHRA / UK coverage (9 compliant certificates vs 2).

On a 13-modality CDMO landscape, both Advent Bioservices and Thermo Fisher Scientific qualify as AAV manufacturers; Thermo Fisher Scientific carries the higher composite Signal Score for AAV programs in this comparison.

What to evaluate for AAV programs

Both Advent Bioservices and Thermo Fisher Scientific qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Platform & scale

Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.

Capsid quality

Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.

Regulatory readiness

For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & timelines

AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.

See all AAV CDMOs ranked by Signal Score →

Frequently asked: Advent Bioservices vs Thermo Fisher Scientific

Which has the stronger FDA inspection record, Advent Bioservices or Thermo Fisher Scientific?

Both Advent Bioservices and Thermo Fisher Scientific maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Advent Bioservices has 0 FDA inspections on record; Thermo Fisher Scientific has 5.

How do Advent Bioservices and Thermo Fisher Scientific compare on European GMP coverage?

Advent Bioservices holds 0 active EMA GMP certificates and 2 MHRA / UK certificates. Thermo Fisher Scientific holds 1 active EMA GMP certificate and 9 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — Advent Bioservices or Thermo Fisher Scientific?

Advent Bioservices is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Thermo Fisher Scientific is matched to 2. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

Which is better for AAV manufacturing — Advent Bioservices or Thermo Fisher Scientific?

Both Advent Bioservices and Thermo Fisher Scientific are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.

What does the Signal Score gap mean in practice?

Advent Bioservices carries a Signal Score of 78/100 and Thermo Fisher Scientific carries 83/100 — a small lead for Thermo Fisher Scientific. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Advent Bioservices and Thermo Fisher Scientific for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.